Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Preferred Shares Issued (2017 - 2023)

Fortress Biotech (FBIO) has 8 years of Preferred Shares Issued data on record, last reported at $652000.0 in Q1 2023.

  • For Q1 2023, Preferred Shares Issued changed N/A year-over-year to $652000.0; the TTM value through Mar 2024 reached $652000.0, changed 0.0%, while the annual FY2021 figure was $17.0 million, 56.57% down from the prior year.
  • Preferred Shares Issued reached $652000.0 in Q1 2023 per FBIO's latest filing, down from $4.2 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $25.9 million in Q2 2020 and bottomed at $263000.0 in Q2 2021.
  • Average Preferred Shares Issued over 4 years is $9.0 million, with a median of $6.0 million recorded in 2019.
  • Peak YoY movement for Preferred Shares Issued: skyrocketed 628.26% in 2019, then crashed 98.98% in 2021.
  • A 4-year view of Preferred Shares Issued shows it stood at $6.0 million in 2019, then soared by 118.62% to $13.2 million in 2020, then plummeted by 68.4% to $4.2 million in 2021, then crashed by 84.37% to $652000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Preferred Shares Issued were $652000.0 in Q1 2023, $4.2 million in Q3 2021, and $263000.0 in Q2 2021.